Moderna (MRNA) Stock Price Today, Real-Time Quotes, Forecasts

Moderna (MRNA) Stock: Real Time Chart and Quotes

Stock Consensus Rating = "Buy"
Lowest Price Target
$102.00
Average target price
$177.00
Maximum target price
$296.00
Moderna (MRNA) Stock
Moderna
MRNA
Stock = Moderna, Inc.
ISIN = US0231351067
About company = Moderna Inc. is a US biotech company. Develops drugs and vaccines. Based in Cambridge (Massachusetts). He is engaged in the development of innovative drugs based on matrix ribonucleic acid (mRNA).

Moderna (MRNA) Stock Forecasts, Predictions

On December 16, 2022, analytical firm “Morgan Stanley” published a latest price target for Moderna (MRNA) stock of $209.00 for the next 12 months. 28 analyst firms have released forecasts for Moderna (MRNA) stock over the past year. The consensus rating of analytical firms is “Buy”. Analysts’ average target price is $177.00. See the table below for the latest price targets and analyst forecasts for Moderna (MRNA) shares.

Moderna (MRNA) Latest Price Targets

Forecast dateAnalytical firm Change target price Rating
12/16/2022 Morgan Stanley
$170→$209
Equal-Weight
12/14/2022 Chardan Capital
$186→$191
Neutral
12/13/2022 SVB Leerink
$101→$102
Market Perform
11/07/2022 Chardan Capital
$188→$186
Buy
11/04/2022 Morgan Stanley
$175→$170
Equal-Weight
10/24/2022 JP Morgan
$165→$122
Neutral
10/21/2022 SVB Leerink
$74→$101
Market Perform
10/18/2022 Morgan Stanley
$197→$175
Equal-Weight
10/13/2022 Goldman Sachs
$290→$296
Buy
09/14/2022 Argus Research
$180→$150
Buy
09/08/2022 Deutsche Bank
$155→$165
Buy
08/04/2022 SVB Leerink
$77→$74
Underperform
08/04/2022 Morgan Stanley
$199→$197
Equal-Weight
08/01/2022 SVB Leerink
$70→$77
Underperform
06/07/2022 SVB Leerink
$80→$70
Underperform
05/18/2022 Piper Sandler
$348→$214
Overweight
05/05/2022 Morgan Stanley
$217→$199
Equal-Weight
03/07/2022 Deutsche Bank
$175→$155
Hold
01/21/2022 UBS →$221→ Neutral
01/21/2022 B of A Securities
$135→$180
Underperform → Neutral

Alex Belov

Developers by oneinveststock.com. Analyst, investor